A double-blind, placebo-controlled, randomized trial of oral sodium clodronate for metastatic prostate cancer (MRC PR05 Trial). [electronic resource]
Producer: 20030917Description: 1300-11 p. digitalISSN:- 1460-2105
- Administration, Oral
- Aged
- Analgesics, Non-Narcotic -- administration & dosage
- Androgen Antagonists -- administration & dosage
- Antineoplastic Agents, Hormonal -- administration & dosage
- Bone Neoplasms -- complications
- Clodronic Acid -- administration & dosage
- Digestive System -- drug effects
- Diphosphonates -- administration & dosage
- Disease-Free Survival
- Double-Blind Method
- Drug Administration Schedule
- Drug Therapy, Combination
- Humans
- Imidazoles -- administration & dosage
- Male
- Middle Aged
- Odds Ratio
- Pain -- etiology
- Prostatic Neoplasms -- drug therapy
- Research Design
- Survival Analysis
- Treatment Outcome
- United Kingdom
- Zoledronic Acid
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.